Becker’s Hospital Review highlights the discoveries made in HSS laboratories led by Mary K. Crow, MD, physician-in-chief emerita, contributing to a new treatment option approved by the US Food and Drug Administration for adults with moderate to severe systemic lupus erythematosus.

Dr. Crow’s laboratories were among the first three groups to publish research defining the link between interferon and lupus in 2003.

“As an investigator who focuses on translational research, my goal is always to discover something that can benefit patients. It's very gratifying when your research can have a positive impact on people's lives,” said Dr. Crow.

Read the full article at Beckershospitalreview.com.